NCT02079168View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Keloid
Interventions
DRUG

RXI-109

DRUG

Placebo

Trial Locations (3)

33137

Miami

63141

St Louis

Unknown

San Cristóbal

All Listed Sponsors
lead

RXi Pharmaceuticals, Corp.

INDUSTRY

NCT02079168 - A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults | Biotech Hunter | Biotech Hunter